IRIS
SALVATORE, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.330
NA - Nord America 4.640
EU - Europa 4.396
SA - Sud America 720
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AN - Antartide 1
Totale 15.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.467
SG - Singapore 2.482
RU - Federazione Russa 1.779
IT - Italia 1.159
VN - Vietnam 949
CN - Cina 925
BR - Brasile 588
HK - Hong Kong 473
DE - Germania 262
UA - Ucraina 237
FR - Francia 197
FI - Finlandia 174
NL - Olanda 169
GB - Regno Unito 120
CA - Canada 108
IN - India 102
JP - Giappone 77
AR - Argentina 61
CI - Costa d'Avorio 58
IE - Irlanda 54
ZA - Sudafrica 54
BD - Bangladesh 45
PL - Polonia 44
ES - Italia 43
SE - Svezia 43
MX - Messico 39
KR - Corea 38
IQ - Iraq 31
TR - Turchia 31
AT - Austria 29
PH - Filippine 28
ID - Indonesia 21
PK - Pakistan 19
TH - Thailandia 18
TW - Taiwan 17
EC - Ecuador 16
BE - Belgio 15
NG - Nigeria 15
CO - Colombia 14
SA - Arabia Saudita 12
UZ - Uzbekistan 12
PY - Paraguay 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
MA - Marocco 9
CZ - Repubblica Ceca 8
KE - Kenya 8
LT - Lituania 8
SK - Slovacchia (Repubblica Slovacca) 8
EG - Egitto 7
MY - Malesia 7
SN - Senegal 7
BG - Bulgaria 6
CH - Svizzera 6
HN - Honduras 6
JO - Giordania 6
UY - Uruguay 6
DK - Danimarca 5
PE - Perù 5
TN - Tunisia 5
BO - Bolivia 4
CL - Cile 4
JM - Giamaica 4
NP - Nepal 4
PT - Portogallo 4
AL - Albania 3
AU - Australia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
KW - Kuwait 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
Totale 15.262
Salva come PNG Salva come JPEG
Città #
Singapore 1.139
San Jose 726
Hong Kong 455
Moscow 426
Ashburn 404
Naples 386
Ho Chi Minh City 289
Chandler 284
Beijing 263
Jacksonville 217
Hanoi 205
Santa Clara 173
Amsterdam 139
Hefei 135
Lauterbourg 126
Los Angeles 118
Millbury 116
Napoli 95
Boston 93
The Dalles 93
Princeton 86
Munich 78
New York 72
Buffalo 70
Wilmington 62
São Paulo 57
Tokyo 57
Nanjing 56
Turku 48
Haiphong 47
Ottawa 46
Redondo Beach 43
Lawrence 41
Orem 41
Dallas 39
Council Bluffs 38
Des Moines 37
Warsaw 34
Da Nang 32
Houston 32
Nuremberg 30
Chicago 29
Brooklyn 27
Helsinki 27
Milan 27
Montreal 26
Johannesburg 25
Seattle 25
Frankfurt am Main 24
Salerno 24
Seoul 24
Stockholm 24
Kochi 23
Poplar 22
Norwalk 21
Phoenix 21
Rome 21
Chennai 20
Hebei 20
Shenyang 20
San Giovanni Rotondo 19
Mexico City 18
Nanchang 17
Belo Horizonte 16
Denver 16
Dong Ket 16
Rio de Janeiro 16
Abuja 14
Atlanta 14
Thái Nguyên 14
Toronto 14
Washington 14
Ann Arbor 13
Santa Maria Capua Vetere 13
Afragola 12
Florence 12
Lappeenranta 12
Okayama 12
Santa Maria 12
Tianjin 12
Vienna 12
Boardman 11
Can Tho 11
Changsha 11
Curitiba 11
Hải Dương 11
London 11
Ottaviano 11
San Francisco 11
Thái Bình 11
Aversa 10
Biên Hòa 10
Shanghai 10
Tashkent 10
Woodbridge 10
Avellino 9
Bangkok 9
Brasília 9
Casoria 9
City of London 9
Totale 7.870
Salva come PNG Salva come JPEG
Nome #
Spot-light on microbiota in obesity and cancer 211
The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress 196
Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch 194
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis 184
Exposure to artificial light at night: A common link for obesity and cancer? 183
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage 180
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms 178
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling 175
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 170
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 166
The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells 166
Thyroid hormone enhances angiogenesis and the warburg effect in squamous cell carcinomas 166
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence 161
Deiodinases and their intricate role in thyroid hormone homeostasis 161
Beta-Catenin Regulates Deiodinase Levels and Thyroid Hormone Signaling in Colon Cancer Cells 155
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 155
Calcium interaction with bovine Thyroglobulin: Stoichiometry and structural consequences of calcium binding. 149
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 148
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice 147
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 147
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 145
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 144
Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences 143
Author Correction: Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch (Nature Communications, (2019), 10, 1, (5410), 10.1038/s41467-019-13140-2) 142
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 135
Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi 135
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives 135
Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells 129
Advances in functional imaging of differentiated thyroid cancer 128
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib 127
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 127
A Type 2 Deiodinase-Dependent Increase in Vegfa Mediates Myoblast-Endothelial Cell Crosstalk during Skeletal Muscle Regeneration 126
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results 125
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 125
Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis 124
Thyroid hormone action in muscle atrophy 124
Type 3 deiodinase and solid tumors: an intriguing pair. 123
Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis. 123
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 122
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. 122
The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. 122
Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression 122
Identification and functional characterization of a novel mutation in the NKX2-1 gene: Comparison with the data in the literature 122
Calcium interaction with bovine thyroiglobulin: stoichiometry and structural consequences of calcium binding 121
Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation 121
Methods and Products for Treating Proliferative Disorders. 121
Local ablative therapy of oligoprogressive TKI-treated thyroid cancer 121
Endemic goiter and iodine deficiency diffusion in province of Avellino 117
Identification and Functional Characterization of a Novel Mutation in theNKX2-1Gene: Comparison with the Data in the Literature 117
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 115
Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3 114
A Global Loss of Dio2 Leads to Unexpected Changes in Function and Fiber Types of Slow Skeletal Muscle in Male Mice 114
Widespread endemic goiter and iodine deficiency in the province of Avellino 112
The importance of the RET gene in thyroid cancer and therapeutic implications 112
Teriparatide replacement therapy for hypoparathyroidism during treatment with lenvatinib for advanced thyroid cancer: A case report 111
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients 110
The different cardiac expression of the Type 2 Iodothyronine deiodinase gene between human and rat is related to the differential response of the dio2 genes to NKX-2.5 and GATA-4 transcription factors 110
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. 110
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 110
Transcription factor Nkx-2.5 induces sodium/iodidesymporter gene expression and participates in retinoic acid- andlactation-induced transcription in mammary cells. 109
Tiroide è Donna 109
The selective loss of the Type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism 109
Deiodinases in thyroid tumorigenesis 109
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 108
The relevance of T3 in the management of hypothyroidism 108
Deiodinases and Cancer 105
Role of type 3 deiodinase in cancer. 104
p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome 103
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? 102
On the governance of incentives to innovate: Can Open Source models be applied to drug development? 102
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back 102
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next? 101
APPROCCIO CLINICO AL PAZIENTE CON GOZZO 100
CHERACTERIZATION OF THE 5'-FLANKING AND 5'UNTRANSLATED REGIONS OF THE CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-RESPONSIVE HUMAN TYPE 2 DEIODINASE GENE. 99
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. 99
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 98
A 21 year old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase 98
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. 97
Type 2 Iodothyronine Deiodinase Levels Are Higher in Slow-Twitch than Fast-Twitch Mouse Skeletal Muscle and Are Increased in Hypothyroidism 97
Biochemistry, cellular and molecular biology, and physiological role of the iodothyronine selenodeiodinases 96
Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27 rats 96
CLONING OF THE RAT TISSUE INHIBITOR OF METALLOPROTEINASE TYPE 2 (timp-2) GENE; ANALYSIS OF ITSEXPRESSION IN NORMAL AND TRASFORMED THYROID CELLS. 93
PTC IN THYROID TUMORS 93
FREQUENT RET PROTO-ONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (MEN2A). 93
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 93
Pendrin is a Novel In Vivo Downstream Target Gene of the TTF-1/Nkx-2.1 Homeodomain Transcription Factor in Differentiated Thyroid Cells 93
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. 91
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 91
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle 91
Deiodination in cancer growth: the role of type III deiodinase 90
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 90
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 89
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 88
RET\PTC activation in human thyroid carcinomas 88
MUTATION OF SECYS RESIDUE 266 IN HUMAN D2 SELENODEIODINASE ALTERS 75Se INCORPORATION WITHOUT AFFECTING THE BIOCHEMICAL PROPERTIES. 87
Studies of molecular mechanisms associated with increased deiodinase 3 expression in a case of consumptive hypothyroidism. 87
The unique signature of tyrosine kinase inhibitor-induced hypothyroidism 85
MOLECULAR BIOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF THE HUMAN TYPE 2 SELENODEIODINASE. 85
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. 85
Liver expression in Cystic Fibrosis could be modulated by genetic factors different from the Cystic Fibrosis Transmembrane Regulator genotype. 84
Totale 12.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 17 70 17
2021/2022908 21 61 33 24 26 14 36 28 74 63 235 293
2022/2023905 137 76 24 34 88 80 7 62 143 138 61 55
2023/2024867 54 137 154 83 49 72 16 80 26 18 116 62
2024/20254.212 215 263 34 40 111 248 467 242 312 430 1.446 404
2025/20267.170 915 502 769 824 1.263 345 856 419 850 427 0 0
Totale 15.505